| 000 | 01804 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518094046.0 | ||
| 264 | 0 | _c20200701 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1016/j.annonc.2020.03.300 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMichot, J-M | |
| 245 | 0 | 0 |
_aTocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _c07 2020 |
||
| 300 |
_a961-964 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAutoantibodies _xtherapeutic use |
| 650 | 0 | 4 | _aBetacoronavirus |
| 650 | 0 | 4 | _aCOVID-19 |
| 650 | 0 | 4 |
_aCoronavirus Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPandemics |
| 650 | 0 | 4 |
_aPneumonia, Viral _xcomplications |
| 650 | 0 | 4 |
_aReceptors, Interleukin-6 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRespiratory Insufficiency _xdiagnostic imaging |
| 650 | 0 | 4 | _aSARS-CoV-2 |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAlbiges, L | |
| 700 | 1 | _aChaput, N | |
| 700 | 1 | _aSaada, V | |
| 700 | 1 | _aPommeret, F | |
| 700 | 1 | _aGriscelli, F | |
| 700 | 1 | _aBalleyguier, C | |
| 700 | 1 | _aBesse, B | |
| 700 | 1 | _aMarabelle, A | |
| 700 | 1 | _aNetzer, F | |
| 700 | 1 | _aMerad, M | |
| 700 | 1 | _aRobert, C | |
| 700 | 1 | _aBarlesi, F | |
| 700 | 1 | _aGachot, B | |
| 700 | 1 | _aStoclin, A | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 31 _gno. 7 _gp. 961-964 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.annonc.2020.03.300 _zAvailable from publisher's website |
| 999 |
_c30815199 _d30815199 |
||